Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Valvular Heart Disease

Free Subscription Articles published in PLoS One Retrieve available abstracts of 47 articles: HTML format Text format

Single Articles

January 2018
1. FREYTSIS M, Baugh L, Liu Z, Georgakoudi I, et al
   Conditional deletion of RB1 in the Tie2 lineage leads to aortic valve regurgitation.
   PLoS One. 2018;13:e0190623.
   PubMed     Text format     Abstract available
   
   
   
2. SCHAEFER A, Dickow J, Schoen G, Westhofen S, et al
   Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis.
   PLoS One. 2018;13:e0191171.
   PubMed     Text format     Abstract available
   
   
   
3. PUJADES-RODRIGUEZ M, Guttmann OP, Gonzalez-Izquierdo A, Duyx B, et al
   Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.
   PLoS One. 2018;13:e0191214.
   PubMed     Text format     Abstract available
   
   
   
4. ZHAI S, Xu H, Fan C, Yang Y, et al
   Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy.
   PLoS One. 2018;13:e0192218.
   PubMed     Text format     Abstract available
   
   
   
5. BORGEAT K, Niessen SJM, Wilkie L, Harrington N, et al
   Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease.
   PLoS One. 2018;13:e0194342.
   PubMed     Text format     Abstract available
   
   
   
6. CASQUEL DE TOMASI L, Salome Campos DH, Grippa Sant'Ana P, Okoshi K, et al
   Pathological hypertrophy and cardiac dysfunction are linked to aberrant endogenous unsaturated fatty acid metabolism.
   PLoS One. 2018;13:e0193553.
   PubMed     Text format     Abstract available
   
   
   
7. WURSCHINGER F, Wittmann S, Goldfuss S, Zech N, et al
   Complications after transcatheter aortic valve implantation using transfemoral and transapical approach in general anaesthesia.
   PLoS One. 2018;13:e0193558.
   PubMed     Text format     Abstract available
   
   
   
8. ORTIZ-ROMERO P, Borralleras C, Bosch-Morato M, Guivernau B, et al
   Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model.
   PLoS One. 2018;13:e0194476.
   PubMed     Text format     Abstract available
   
   
   
9. LIN J, Qin Z, Qian H, Li Y, et al
   A novel catheter with retractable stent that can prevent aortic insufficiency during left ventricular assist.
   PLoS One. 2018;13:e0194658.
   PubMed     Text format     Abstract available
   
   
   
10. LIU Z, Kidney E, Bem D, Bramley G, et al
    Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0196877.
    PubMed     Text format     Abstract available
    
    
    
11. SATO K, Harb S, Kumar A, Kapadia SR, et al
    Impact of left ventricular diastolic function and survival in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    PLoS One. 2018;13:e0196031.
    PubMed     Text format     Abstract available
    
    
    
12. YOUSEF A, Hibbert B, Feder J, Bernick J, et al
    A novel echocardiographic hemodynamic index for predicting outcome of aortic stenosis patients following transcatheter aortic valve replacement.
    PLoS One. 2018;13:e0195641.
    PubMed     Text format     Abstract available
    
    
    
13. DONATE PUERTAS R, Jalabert A, Meugnier E, Euthine V, et al
    Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation.
    PLoS One. 2018;13:e0196666.
    PubMed     Text format     Abstract available
    
    
    
14. HUSSER D, Ueberham L, Jacob J, Heuer D, et al
    Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-An analysis of over 5 million patients.
    PLoS One. 2018;13:e0196612.
    PubMed     Text format     Abstract available
    
    
    January 2017
15. GREER JM, Hamilton C, McMullon ME, Riby DM, et al
    An event related potential study of ihibitory and attentional control in Williams syndrome adults.
    PLoS One. 2017;12:e0170180.
    PubMed     Text format     Abstract available
    
    
    
16. SONG I, Ko SM, Yi JG, Chee HK, et al
    Differences in Aortic Valve and Left Ventricular Parameters Related to the Severity of Myocardial Fibrosis in Patients with Severe Aortic Valve Stenosis.
    PLoS One. 2017;12:e0170939.
    PubMed     Text format     Abstract available
    
    
    
17. WANG YT, Tao J, Maimaiti A, Adi D, et al
    Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China.
    PLoS One. 2017;12:e0174490.
    PubMed     Text format     Abstract available
    
    
    
18. MARTINS CO, Demarchi L, Ferreira FM, Pomerantzeff PM, et al
    Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.
    PLoS One. 2017;12:e0170191.
    PubMed     Text format     Abstract available
    
    
    
19. MADEMONT-SOLER I, Mates J, Yotti R, Espinosa MA, et al
    Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
    PLoS One. 2017;12:e0181465.
    PubMed     Text format     Abstract available
    
    
    
20. CASOS K, Ferrer-Curriu G, Soler-Ferrer P, Perez ML, et al
    Response of the human myocardium to ischemic injury and preconditioning: The role of cardiac and comorbid conditions, medical treatment, and basal redox status.
    PLoS One. 2017;12:e0174588.
    PubMed     Text format     Abstract available
    
    
    
21. TOPPEN W, Johansen D, Sareh S, Fernandez J, et al
    Improved costs and outcomes with conscious sedation vs general anesthesia in TAVR patients: Time to wake up?
    PLoS One. 2017;12:e0173777.
    PubMed     Text format     Abstract available
    
    
    
22. MASCHERBAUER J, Kammerlander AA, Zotter-Tufaro C, Aschauer S, et al
    Presence of isolated tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction.
    PLoS One. 2017;12:e0171542.
    PubMed     Text format     Abstract available
    
    
    
23. LEE SY, Shim CY, Hong GR, Cho IJ, et al
    Determinants and Prognostic Significance of Symptomatic Status in Patients with Moderately Dysfunctional Bicuspid Aortic Valves.
    PLoS One. 2017;12:e0169285.
    PubMed     Text format     Abstract available
    
    
    
24. DHARMARAJAN K, Foster J, Coylewright M, Green P, et al
    The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: Patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers.
    PLoS One. 2017;12:e0175926.
    PubMed     Text format     Abstract available
    
    
    
25. KOLASA-TRELA R, Konieczynska M, Bazanek M, Undas A, et al
    Specific changes in circulating cytokines and growth factors induced by exercise stress testing in asymptomatic aortic valve stenosis.
    PLoS One. 2017;12:e0173787.
    PubMed     Text format     Abstract available
    
    
    
26. THONGPRAYOON C, Cheungpasitporn W, Thamcharoen N, Ungprasert P, et al
    Association of frailty status with acute kidney injury and mortality after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0177157.
    PubMed     Text format     Abstract available
    
    
    
27. TSUJI M, Kawasaki T, Matsuda T, Arai T, et al
    Sexual dimorphisms of mRNA and miRNA in human/murine heart disease.
    PLoS One. 2017;12:e0177988.
    PubMed     Text format     Abstract available
    
    
    
28. GUERBAII RA, Fustier G, Ennezat PV, Ringle A, et al
    Asymptomatic aortic stenosis: An assessment of patients' and of their general practitioners' knowledge, after an indexed specialized assessment in community practice.
    PLoS One. 2017;12:e0178932.
    PubMed     Text format     Abstract available
    
    
    
29. WANG J, Chandrasekhar V, Abbadessa G, Yu Y, et al
    In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.
    PLoS One. 2017;12:e0178905.
    PubMed     Text format     Abstract available
    
    
    
30. VASSILIOU VS, Flynn PD, Raphael CE, Newsome S, et al
    Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.
    PLoS One. 2017;12:e0181077.
    PubMed     Text format     Abstract available
    
    
    
31. MCNAMARA JW, Li A, Lal S, Bos JM, et al
    MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.
    PLoS One. 2017;12:e0180064.
    PubMed     Text format     Abstract available
    
    
    
32. AUENSEN A, Hussain AI, Falk RS, Walle-Hansen MM, et al
    Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis.
    PLoS One. 2017;12:e0179304.
    PubMed     Text format     Abstract available
    
    
    
33. GUO X, Fan C, Tian L, Liu Y, et al
    The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.
    PLoS One. 2017;12:e0174118.
    PubMed     Text format     Abstract available
    
    
    
34. MENDES DE ALMEIDA R, Tavares J, Martins S, Carvalho T, et al
    Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy.
    PLoS One. 2017;12:e0182946.
    PubMed     Text format     Abstract available
    
    
    
35. ZHANG S, Kolominsky-Rabas PL
    How TAVI registries report clinical outcomes-A systematic review of endpoints based on VARC-2 definitions.
    PLoS One. 2017;12:e0180815.
    PubMed     Text format     Abstract available
    
    
    
36. FUKUMOTO R, Kawai M, Minai K, Ogawa K, et al
    Conflicting relationship between age-dependent disorders, valvular heart disease and coronary artery disease by covariance structure analysis: Possible contribution of natriuretic peptide.
    PLoS One. 2017;12:e0181206.
    PubMed     Text format     Abstract available
    
    
    
37. TEMU TM, Lane KA, Shen C, Ng'ang'a L, et al
    Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.
    PLoS One. 2017;12:e0185204.
    PubMed     Text format     Abstract available
    
    
    
38. SONG Y, Soh S, Shim JK, Park KU, et al
    Skin perfusion pressure as an indicator of tissue perfusion in valvular heart surgery: Preliminary results from a prospective, observational study.
    PLoS One. 2017;12:e0184555.
    PubMed     Text format     Abstract available
    
    
    
39. ELATTAR MA, Vink LW, van Mourik MS, Baan J Jr, et al
    Dynamics of the aortic annulus in 4D CT angiography for transcatheter aortic valve implantation patients.
    PLoS One. 2017;12:e0184133.
    PubMed     Text format     Abstract available
    
    
    
40. DI FRANCO A, Kim J, Rodriguez-Diego S, Khalique O, et al
    Multiplanar strain quantification for assessment of right ventricular dysfunction and non-ischemic fibrosis among patients with ischemic mitral regurgitation.
    PLoS One. 2017;12:e0185657.
    PubMed     Text format     Abstract available
    
    
    
41. MARTINEZ-VARGAS J, Ventura J, Machuca A, Munoz-Munoz F, et al
    Cardiac, mandibular and thymic phenotypical association indicates that cranial neural crest underlies bicuspid aortic valve formation in hamsters.
    PLoS One. 2017;12:e0183556.
    PubMed     Text format     Abstract available
    
    
    
42. PETZOLDT M, Trepte CJ, Ridder J, Maisch S, et al
    Reliability of transcardiopulmonary thermodilution cardiac output measurement in experimental aortic valve insufficiency.
    PLoS One. 2017;12:e0186481.
    PubMed     Text format     Abstract available
    
    
    
43. ORLOWSKA-BARANOWSKA E, Gadomska Vel Betka L, Gora J, Baranowski R, et al
    Functional polymorphism of the renalase gene is associated with cardiac hypertrophy in female patients with aortic stenosis.
    PLoS One. 2017;12:e0186729.
    PubMed     Text format     Abstract available
    
    
    
44. LUNATI ME, Bedeschi MF, Resi V, Grancini V, et al
    Impaired glucose metabolism in subjects with the Williams-Beuren syndrome: A five-year follow-up cohort study.
    PLoS One. 2017;12:e0185371.
    PubMed     Text format     Abstract available
    
    
    
45. VISWANATHAN SK, Sanders HK, McNamara JW, Jagadeesan A, et al
    Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    PLoS One. 2017;12:e0187948.
    PubMed     Text format     Abstract available
    
    
    
46. AOYAMA R, Takano H, Kobayashi Y, Kitamura M, et al
    Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography.
    PLoS One. 2017;12:e0188479.
    PubMed     Text format     Abstract available
    
    
    January 2016
47. AL-RASHID F, Kahlert P, Selge F, Hildebrandt H, et al
    Risk Assessment of Patients Undergoing Transfemoral Aortic Valve Implantation upon Admission for Post-Interventional Intensive Care and Surveillance: Implications on Short- and Midterm Outcomes.
    PLoS One. 2016;11:e0167072.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: